These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 23138021)

  • 1. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
    Murakami R; Sugahara T; Nakamura H; Hirai T; Kitajima M; Hayashida Y; Baba Y; Oya N; Kuratsu J; Yamashita Y
    Radiology; 2007 May; 243(2):493-9. PubMed ID: 17356177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.
    Aldave G; Tejada S; Pay E; Marigil M; Bejarano B; Idoate MA; Díez-Valle R
    Neurosurgery; 2013 Jun; 72(6):915-20; discussion 920-1. PubMed ID: 23685503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging.
    Yamasaki F; Sugiyama K; Ohtaki M; Takeshima Y; Abe N; Akiyama Y; Takaba J; Amatya VJ; Saito T; Kajiwara Y; Hanaya R; Kurisu K
    Eur J Radiol; 2010 Mar; 73(3):532-7. PubMed ID: 19250783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
    Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
    Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy.
    Patwardhan RV; Shorter C; Willis BK; Reddy P; Smith D; Caldito GC; Nanda A
    Surg Neurol; 2004 Sep; 62(3):207-13; discussion 214-5. PubMed ID: 15336860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of prognostic factors in patients with glioblastoma.
    Lutterbach J; Sauerbrei W; Guttenberger R
    Strahlenther Onkol; 2003 Jan; 179(1):8-15. PubMed ID: 12540979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving prognosis of glioblastoma in the 21st century: who has benefited most?
    Lawrence YR; Mishra MV; Werner-Wasik M; Andrews DW; Showalter TN; Glass J; Shen X; Symon Z; Dicker AP
    Cancer; 2012 Sep; 118(17):4228-34. PubMed ID: 22180310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme].
    Jeremić B; Grulicić D; Samardzić M; Antunović V; Joksimović M; Djurić Lj; Milicić B; Nikolić N
    Srp Arh Celok Lek; 1997; 125(3-4):93-8. PubMed ID: 9221525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China.
    Ma X; Lv Y; Liu J; Wang D; Huang Q; Wang X; Li G; Xu S; Li X
    J Clin Neurosci; 2009 Dec; 16(12):1595-8. PubMed ID: 19793663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme.
    De Vleeschouwer S; Fieuws S; Rutkowski S; Van Calenbergh F; Van Loon J; Goffin J; Sciot R; Wilms G; Demaerel P; Warmuth-Metz M; Soerensen N; Wolff JE; Wagner S; Kaempgen E; Van Gool SW
    Clin Cancer Res; 2008 May; 14(10):3098-104. PubMed ID: 18483377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.